Connection

Athimalaipet Ramanan to North America

Back to Details
This is a "connection" page, showing publications Athimalaipet Ramanan has written about North America.
Athimalaipet Ramanan
Connection Strength
0.040
North America
  1. Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial. Lancet Respir Med. 2021 12; 9(12):1407-1418.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.